pharma-and-clinical-pharmacy-congress-2016_tracks

6 / 21

Notes:
Page 29
Pharma & Clinical Pharmacy Congress 2016
November 07-09, 2016
Volume 5 Issue 4(Suppl) Clin Pharmacol Biopharm
ISSN: 2167-065X CPB, an open access journal
conferenceseries .com
November 07-09, 2016 Las Vegas, Nevada, USA
4th International
Pharma & Clinical Pharmacy Congress
Sabah H. Akrawi et al., Clin Pharmacol Biopharm 2016, 5:4(Suppl)
Potentiation of gentamicin induced nephrotoxicity by molsidomine in rats
Sabah H Akrawi1, Marwan S Al Nimer2
1College of Clinical Pharmacy, King Faisal University, Al Hasa , KSA
2College of Medicine, Al Yarmouk University, Baghdad, Iraq
Reactive oxygen metabolites have been implicated in gentamicin induced nephrotoxicity. This study tests whether or
not nephrotoxicity of gentamicin is associated with cellular activation or lipid peroxidation and the use of vasodilator,
molsidomine, plays a role in the renal lesion. Male Wister 200-300 g rats were distributed randomly into five groups, Saline
treated group, Molsidomine treated group, Gentamicin treated group, Molsidomine + Gentamicin treated group, and
Gentamicin + Ethanol treated group. The results showed that gentamicin induced nephrotoxicity was associated with a
significant activation of cellular lipid peroxidation manifested by high serum and cortical tissue malondialdehyde, and the use
of molsidomine aggravates this process. These data indicate that vasodilators and in particular those with nitric oxide (NO)
dinating property may be extremely harmful when used with gentamicin.
Biography
Sabah Akrawi, PhD, graduated from the College of Pharmacy/University of Kentucky/USA. He is an assoc. Prof. of Clinical Pharmacokinetic and Biopharmaceutic
and a faculty member at the College of Clinical Pharmacy/King Faisal University/KSA. He supervised 17 postgraduate pharmacy students, and he has published
more than 26 articles. He is a member of the scientific council of the KFU and chaired many defense committees for graduation of graduate students.